You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
While undergoing parallel review for its FoundationOne test by the FDA and CMS, the firm will continue to work with its local MACs on reimbursement.
The insurer will cover Metamark's urology specialized diagnostics throughout the state.
The blood-based test will be covered by one of the largest health plans in the state of Michigan.
The deal is the latest coverage and reimbursement success for the Cambridge, Massachusetts-based urology diagnostics firm.
The colon cancer screening test is now covered in-network by the insurance company in Indiana, Ohio, Kentucky, Missouri, and Wisconsin.
The insurer is the latest to provide coverage for NanoString's gene expression-based breast cancer recurrence risk test.
Natera said that a greater proportion of NIPTs for average-risk pregnancies are being reimbursed, while reimbursement for microdeletion testing is declining.
Bank of America, Phoenix Children's Hospital, and Sanford Health said they would cover NantHealth's GPS Cancer test for some cancers.
Aetna considers the test "medically necessary" and the decision opens the door for 19 million people to access the risk classifier test.
Sequenom has secured in-network status with seven state Anthem BCBS plans to provide NIPT to both high- and average-risk pregnancies.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.
Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.
According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.
In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.